http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2706270-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_545d3d0f10a10f18a29b2e6fe67f3ce8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8dcacad0a71e8588dd74b0cc2054e52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_538391f01896250b9e47efd82c509c48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c96c3b1da0a9ec2d82939147c9e4381
publicationDate 2011-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2706270-A1
titleOfInvention Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
abstract A multi phase soft gelatin dosage form comprising at least one preformed solid dosage form comprising a statin compound and at least one liquid fill phase comprising Omega-3 fatty acids. The multi phase soft gelatin dosage forms of the present invention are especially useful to combine at least one solid dosage form and at least one liquid phase for single ingestion. The solid phase, liquid phase or coatings may further comprise active pharmaceutical ingredients, nutraceuticals, nutritional supplements, or therapeutic substances, functional excipients or combinations thereof.
priorityDate 2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409588443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425659704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411029818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448850249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16759173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454611257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450470952

Total number of triples: 43.